2008
type: Class

Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Conference Poster
type: Class

Entity
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-21T00:51:44
publisher: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance
label: RDF description of Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance - http://research.umh.es/vivo/pub/comunicacion/65050

Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance
type: Generically Dependent Continuant
most specific type: 2008
related by: AutorExt:116797_2008-Comunicación:65050
most specific type: Conference Poster
type: Congress communication
ARG_2000028: 65050 vcard
type: Anualidad
type: 2008
most specific type: Congress communication
type: Continuant
related by: AutorExt:116796_2008-Comunicación:65050
related by: AutorExt:116799_2008-Comunicación:65050
type: Entity
date time value: 65050 pubdate
related by: Autor:152399-Comunicación:65050
type: Information Content Entity
related by: Autor:152123-Comunicación:65050
RO_0002353: EUFEPS: WHEN VARIABILITY BECOMES AN ISSUE IN DRUG DEVELOPMENT: HOW TO UNDERSTAND, PREDICT AND MANAGE?
type: Conference Poster
type: Thing
type: Document
related by: AutorExt:116798_2008-Comunicación:65050

AutorExt:116797_2008-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance

AutorExt:116796_2008-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance

AutorExt:116799_2008-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance

Autor:152399-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance

Autor:152123-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance

EUFEPS: WHEN VARIABILITY BECOMES AN ISSUE IN DRUG DEVELOPMENT: HOW TO UNDERSTAND, PREDICT AND MANAGE?
type: Anualidad
type: Entity
type: BFO_0000015
type: BFO_0000003
RO_0002234: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance
type: Event
type: Conference
type: Thing
type: 2008

AutorExt:116798_2008-Comunicación:65050
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Simulations of bioequivalence trials using physiological-pharmacokinetic models with saturable and non-saturable hepatic clearance